apremilast
Commercial- Indications
- Plaque psoriasis
Company intelligence / Profile preview
Changzhou Pharmaceutical Factory
Changzhou, Jiangsu, Chinaczpharma.com ↗
- Ownership
- Private
- Employees
- ~1500
- Development stage
- Commercial
01
Overview
Changzhou Pharmaceutical Factory is a leading Chinese pharmaceutical manufacturer with a strong focus on cardiovascular medicines, complex generics, APIs, and finished formulations. The company has multiple products approved by US FDA, EUGMP, PMDA, and CFDA audits. It exports to over fifty countries and collaborates with major global pharma companies.
- Therapeutic areas
- GastroenterologyCardiovascularEndocrinologyInfectious Diseases
- Modalities
- Small moleculeBiologic (for some finished formulations and sterile injectables)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Beyond the preview
Go deeper on Changzhou Pharmaceutical Factory.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Changzhou Pharmaceutical Factory.